Extract

The purpose of this study is to determine the efficacy and safety of three different Tregalizumab doses in combination with Methotrexate (MTX) in subjects who have active rheumatoid arthritis and an inadequate response to MTX alone. The overall study duration is 24 weeks followed by a 24 week extension phase.

Inclusion criteria

• Rheumatoid Arthritis

Country

• Bulgaria
• Canada
• Czech Republic
• Estonia
• Germany
• Hungary
• Lithuania
• Mexico
• Poland
• Russian Federation
• Serbia
• Slovakia
• Ukraine
• United States

Links

• ictrp
• nct